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Most studies of tea trees have focused on their ornamental properties, there are fewer
published studies on their medical values. The purpose of this study was to compare the
chemical constituents and the biological potential of the water extract of leaves in eight
species of Camellia including Camellia sinensis. Among eight Camellia species, Camellia
sasanqua showed potent anticancer activities in prostate cancer PC3 cells. In addition to
catechins, the major component, eugenyl b-primeveroside was detected in C. sasanqua.
Eugenyl b-primeveroside blocked the progression of cell cycle at G1 phase by inducing p53
expression and further upregulating p21 expression. Moreover, eugenyl b-primeveroside
induced apoptosis in PC3 prostate cancer cells. Our results suggest that C. sasanqua may
have anticancer potential.
Copyright © 2015, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan
LLC. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Prostate cancer is the most commonly diagnosed disease and




/licenses/by-nc-nd/4.0/).in the USA [1]. Despite recent advances in surgery, radiation
therapy, hormonal therapy, and medical management, clin-
ical management of advanced prostate cancer is still chal-
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prostate cancer [2].
The genus Camellia (Theaceae) attracts considerable
attention due to its great economic value, broad geographic
distribution, and remarkable species diversity. The main
economic value of Camellia is the production of tea from the
young leaves of Camellia sinensis. Tea is one of themost widely
consumed nonalcoholic beverages in the world and shows
marked benefits to human health, such as providing antioxi-
dant activity and reducing the risk of cancer [3]. Moreover, the
extract from Camellia oleifera seed has been primarily used as
cooking oil [4]. In addition, other species such as Camellia
sasanqua, Camellia reticulata, and Camellia japonica are culti-
vated in temperate regions worldwide as ornamentals.
The quality of the processed tea product depends on the
chemical composition of the tea. These chemical composi-
tions affecting taste and mouth feel of tea are also speculated
to provide potential health benefits [5]. The compounds
determining taste and astringency of tea include catechins,
theaflavins, flavonoids, and thearubigins. Some major cate-
chins present in tea are: ()-epigallocatechin gallate (EGCG);
()-epigallocatechin (EGC), ()-epicatechin gallate (ECG),
()-epicatechin (EC), (þ)-catechin (C), ()-gallocatechin (GC),
()-gallocatechin gallate (GCG), and catechin gallate (CG) [6].
Catechins constitute about 25% dry weight of fresh tea leaf;
total catechin content varies widely depending on species,
light variation, altitude of growing, location, clonal variation,
and season [7e10].
Numerous studies have reported the biological activities of
C. sinensis [11], but few studies have discussed the biological
potential of the other species of Camellia. In the present paper,
we compared eight species of Camellia with C. sinensis. To
investigate the health benefits of eight species of Camellia, the
leaves were directly extracted with hot water. To assess the
effect of anticancer activities, the experiments were per-
formed using PC3 human prostate cancer cells. The objectives
of this paper are to: (1) analyze the content of caffeine and
catechins of various species of Camellia; and (2) evaluate the
bioactivities of various species of Camellia in PC3 prostate
cancer cells.2. Materials and methods
2.1. Chemicals and reagents
EGCG, EGC, ECG, EC, C, GC, GCG, CG, 3-(4,5-dimethylthiaxol-2-
yl)-2,5-diphenyl tetrazolium bromide (MTT), propidium iodide
(PI), and antibodies for b-actin were purchased from Sigma
Chemical Co (St. Louis, MO, USA). Dimethyl sulfoxide (DMSO)
and sodium dodecyl sulfate (SDS) were purchased fromMerck
Co (Darmstadt, Germany). Antibodies for caspase-3, caspase-
9, poly(ADP-ribose) polymerase (PARP), p21, and p53 were
purchased from Cell Signaling Technology (Beverly, MA, USA).
2.2. Preparation of samples
Fresh leaves were obtained from the Tea Flower Manor (Ping
Xi, Taipei, Taiwan). There are eight species of Camellia in this
study including C. oleifera Abel., C. sasanqua Thunb., C.tenuifolia (Hay) Cohen-Stuart, C. japonica cv. “Carp's Eye”, C.
japonica cv. “Cantonese Pink”, C. japonica cv. “Early Spring”, C.
japonica cv. “Kramer's Supreme”, and C. japonica cv. “Nine
Bends”. Samples of fresh leaves (1 g) were placed in boiling
distilled water (100 mL) for 30 minutes and then the infusion
was filtered through a 0.45 mm polyvinylidene difluoride
(PVDF) filter (Millipore, Bedford, MA, USA). The filtrate was
analyzed with high-performance liquid chromatography
(HPLC) as described below. The filtrate was dried under
reduced pressure using a rotavapor to afford powdered crude
extract and kept in a refrigerator at 20C until use. In the
following experiments, the extraction was dissolved in DMSO
(100 mg/mL) and diluted to the desired concentrations.
2.3. Reverse-phase HPLC analysis of catechins and
caffeine
The composition of catechins and caffeine in different species
of Camellia leaves were analyzed by reverse-phase HPLC using
a Waters 600E system controller [10,12]. The Waters 484
tunable absorbance detector was used to detect the constitu-
ents at 280 nm, and all peaks were plotted and integrated by a
Waters 745 data module. The HPLC set consisted of a
250 mm  4.6 mm i.d., 5 mm Cosmosil 5 C18-MS packed col-
umn (Nacalai Tesque, Kyoto, Japan). The extracts of different
species of Camellia leaves were filtered through a 0.45 mmfilter
disk and then injected into the column. The concentrations of
catechins and caffeine working solutions were 100 mg/mL.
Each authentic standard compound (500 ng, catechins and
caffeine) was injected. Briefly, themobile phase set consists of
a mixture of methanolewatereformic acid (19.5:82.5:0.3) at
the flow rate of 1 mL/min. Identification of caffeine or indi-
vidual catechins was based on the comparison of the reten-
tion times of unknown peaks to those of reference authentic
standards. The amount of each constituent in different spe-
cies of Camellia leaves extract was determined by the inte-
grated data provided by the Waters data module.
2.4. Cell culture
All cell lines were obtained from the American Type Culture
Collection (Manassas, VA, USA). The human prostate cancer
cell line used in this studywas PC3.We also used the PZ-HPV-7
cell line, whichwas derived from epithelial cells cultured from
the normal peripheral zone of the prostate and were trans-
formed by HPV18 E6 transforming region oncoprotein,
expressed negative for prostate specific antigen. Human
prostate PC3 cancer cells were grown in RPMI-1640 media
(Invitrogen, Carlsbad, CA, USA) supplemented with 10% fetal
bovine serum (Invitrogen) and 1% penicillin-streptomycin
(Invitrogen). PZ-HPV-7 was cultured in Keratinocyte Serum
Free Medium (Invitrogen), supplied with bovine pituitary
extract and epidermal growth factor. These cells were grown
at 37C in a humidified atmosphere of 5% CO2.
2.5. Cell viability
The cell viability was measured by MTT assay [13]. PC3 cells
were dispensed in 24-well plates at a density of 2  104 cells
per well. After overnight incubation, PC3 cells were treated
j o u r n a l o f f o o d and d ru g an a l y s i s 2 4 ( 2 0 1 6 ) 1 0 5e1 1 1 107with various concentrations of samples at 37C for 48 hours.
At the end of experiments, 40 mL MTT solution (2 mg/mL) was
added to each well for 2 hours. The formazan crystal formed
was dissolved in DMSO. Results were measured using a
microplate reader at 590 nm. Experiments were carried out in
triplicate.2.6. Western blot analysis
PC3 cells treated with various crude extracts were lysed at the
time indicated. Equal amount of cell lysates were electro-
phoresed on SDS-polyacrylamide gels. The proteins were
transferred to the PVDF membrane and incubated with pri-
mary antibodies recognizing caspase-3, caspase-9, PARP, p21,
p53, and b-actin. The membranes were then incubated with
horseradish peroxidase-conjugated secondary antibodies for
60 minutes and developed using enhanced chem-
iluminescence (ECL; Millipore, Watford, Herts, UK) [14].2.7. Statistics
All values are expressed as mean ± standard deviation. Each
value is the mean of at least three separate experiments in
each group. All data were analyzed with a paired t test. As-
terisks indicate that the value is significantly different from
that of the control (* p < 0.05; ** p < 0.01; *** p < 0.001).3. Results
3.1. Inhibition of PC3 cell proliferation by different
species of Camellia
The cytotoxic effect of eight species of Camellia and C. sinensis
was first evaluated in human prostate cancer PC3 cells. As
shown in Fig. 1, treatment with 12.5e200 mg/mL different
species of Camellia extracts caused a dose-dependent decrease
of cell viability. Our result showed that in addition to C.
sinensis, C. sasanqua has good antiproliferative activity in PC3
cells.Fig. 1 e Effect of different species of Camellia (C.) extracts on the
incubation with different concentrations of Camellia extracts at 3
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide a
that of the vehicle-only control. This experiment was repeated3.2. Induction of apoptosis by different species of
Camellia
The different species of Camellia possess potential cytotoxic
effect, so we next examined whether they could induce
apoptosis in PC3 cells. The caspase-3 substrate PARP will be
cleaved when cells undergo apoptosis. Therefore, we exam-
ined the presence of these cleavage products by western
blotting. Our result showed that different species of Camellia
extracts induced apoptosis in PC3 cells. Moreover, it appeared
that the potency of C. sasanqua is higher than that of C. sinensis
in PARP cleavage (Fig. 2).
3.3. HPLC analysis of catechins and caffeine in different
species of Camellia
We compared the compositions of catechins and caffeine in
eight different species of Camellia with C. sinensis by HPLC. As
shown in Table 1, the composition of catechins and caffeine in
variety species of Camellia are different from that of C. sinensis
both qualitatively and quantitatively. Most species of Camellia
contain caffeine and catechins, although caffeine is unde-
tectable in C. japonica cv. “Cantonese Pink”. It is worthy to note
that our previous studies and others have demonstrated that
EGCG was the most abundant catechin and performed the
major bioactivity for anticancer effect in C. sinensis [15,16].
However, the most active catechin, EGCG was lower in eight
species of Camellia than C. sinensis. Moreover, C. oleifera Abel.
possessed the greatest amount of CG, and C. tenuifolia (Hay.)
Cohen-Stuart possessed the greatest amount of C and EC
among these different species of Camellia. Interestingly,
although the catechins were lower, some species such as C.
sasanqua still had potent bioactivity.
3.4. Profile of constituents in C. sasanqua
It is likely that bioactive molecules other than catechins exist
in C. sasanqua, so we next identified the chemical constituents
of C. sasanqua by liquid chromatography/tandem mass spec-
trometry analyses. As shown in Fig. 3A, several constituents
in addition to catechins have been identified in C. sasanqua.proliferation of human prostate cancer PC3 cells. After
7C for 48 hours, the effect on cell growth was examined by
ssay. The percentage of viable cells was compared with
three times. Bars represent the standard deviation.
Fig. 2 e Effect of different species of Camellia extracts on the
cleavage of poly(ADP-ribose) polymerase (PARP) in PC3
cells. PC3 cells were treated with 200 mg/mL of Camellia
water extracts from: (1) dimethyl sulfoxide only as control;
(2) C. sinensis; (3) C. oleifera Abel.; (4) C. tenuifolia (Hay.)
Cohen-Stuart; (5) C. japonica cv. “Carp's Eye”; (6) C. japonica
cv. “Cantonese Pink”; (7) C. sasanqua Thunb.; (8) C. japonica
cv. “Early Spring”; (9) C. japonica cv. “Kramer's Supreme”;
(10) C. japonica cv. “Nine Bends” at 37C for 48 hours.
Immunoblotting was used to measure the preformed and


















































































































































































































































































































































































































































































































































































































































































































































































































j o u rn a l o f f o o d a nd d r u g an a l y s i s 2 4 ( 2 0 1 6 ) 1 0 5e1 1 1108The major peak was determined as eugenyl b-primeveroside
(Fig. 3B). Eugenyl b-primeveroside was found to have a mo-
lecular formula of C21H29O11 based on an electrospray ioni-
zation mass spectrometry (ESI-MS) ion at m/z 457 [M þ H]þ.
Analysis of the heteronuclear multiple-bond correlations
(HMBCs) were used to connect the correlation spectroscopy
(COSY) fragments and assign the quaternary carbons
(supplementary Fig. 1). Specifically, HMBCs from the anomeric
hydrogens resonating at dH 4.83 (H-10) and 4.29 (H-100) to dC
146.2 (C-1) and 69.66 (C-60) completed the sugar portion of the
glycoside moiety. The remainder of the fragments were
assigned on the basis of HMBCs from the methylene hydro-
gens at C-60 (dH4.07 and 3.75) to dC 77.4 (C-50), 71.36 (C-40), and
105.29 (C-100). Further HMBC correlations from the C-500 meth-
ylene hydrogens to the C-10 0 (dC105.29), C-30 0 (dC 77.59), C-40 0 (dC
71.18; supplementary Fig. 1). The molecular formula and 1H
and 13C nuclear magnetic resonance spectroscopic data of the
isolated compound was identical to eugenyl b-primeveroside














































































































































































































































































































































































































































































.3.5. Eugenyl b-primeveroside induces PC3 cells G1 arrest
and apoptosis
To investigate the bioactivity of eugenyl b-primeveroside in
prostate cells, we treated PC3 cells with different concentra-
tions of eugenyl b-primeveroside for 48 hours, and assessed
cell proliferation by MTT assay. As shown in Fig. 4A, the
growth of PC3 cells was inhibited by eugenyl b-primeveroside
in a dose-dependent manner. Importantly, eugenyl b-prime-
veroside was less toxic to normal cell type PZ-HPV-7 (Fig. 4A).
These data indicate that eugenyl b-primeveroside induces
selective cytotoxicity in human prostate cancer cells but less
in normal cells. To examine whether eugenyl b-primeveroside
produced cytotoxic effects, we used a PI stain to measure flow
cytometrically. After treatment with 80mM eugenyl b-prime-
veroside, the cell cycle of PC3 arrested in the G1 phase and the
cells underwent apoptosis (Fig. 4B). Moreover, we examined
the expression of G1 related cell cycle control proteins and
apoptosis related proteins on western blot analysis. PC3 cells
Fig. 3 e (A) Isocratic high-performance liquid chromatography separation of C. sasanqua; (B) structures of eugenyl b-
primeveroside.
j o u r n a l o f f o o d and d ru g an a l y s i s 2 4 ( 2 0 1 6 ) 1 0 5e1 1 1 109were treated with 80mM eugenyl b-primeveroside with indi-
cated durations. Western blot analysis indicated that treat-
ment of PC3 cells with 80mMeugenyl b-primeveroside resulted
in a clear apoptosis within 72 hours, showing cleavages for
PARP, upregulation of caspase-9 and caspase-3 inwestern blot
analyses (Fig. 4C). After 24 hours of eugenyl b-primeveroside
treatment, we could observe increased levels of p21 and p53 in
PC3 cells (Fig. 4D). These results demonstrate that eugenyl b-
primeveroside induced G1 arrest and apoptosis in PC3 cells.4. Discussion
Cancer preventive activity of tea and tea constituents has
been studied in many different models of carcinogenesis [18].
In this study, we used the MTT assay and PARP cleavage to
compare the capability of eight species of Camellia and C.
sinensis to inhibit proliferation and induce apoptosis in human
prostate cancer PC3 cells. Interestingly, our results demon-
strated that some Camellia species other than C. sinensis
showed a significant effect on anti-proliferation and apoptosis
induction. C. sasanqua showed a particularly good anti-
proliferative effect similar to that in C. sinensis. The induction
of apoptosis by C. sasanqua was even more powerful than C.
sinensis (Fig. 2).
According to previous reports, the major components in
tea leaves are caffeine and catechins. Catechins have been
extensively studied for their cancer preventive effects [19].
Accumulating evidence has shown that green tea catechins,
like EGCG, have strong antioxidant activity and affect several
signal transduction pathways relevant to cancer development
[11]. In this report, the occurrence of catechins (namely gallic
acid, GC, EGC, C, EC, EGCG, GCG, ECG, and CG) and caffeine in
eight species of Camellia has been demonstrated by HPLCanalysis (Table 1). The levels of catechins and caffeine inmost
species of Camellia are lower than that of C. sinensis. The
amount of caffeine is lower in eight species of Camellia than C.
sinensis as indicated in Table 1.
C. sasanqua is a species of Camellia native to China and
Japan, and usually grows at an altitude of 900 m. The leaves of
C. sasanqua are used to make tea while the seeds or nuts are
used to make tea seed oil, which is used for lighting, lubrica-
tion, cooking, and cosmetic purposes [20e22]. A previous
study [23] reported that a novel 3,4-seco-triterpene alcohol,
named sasanquol, was isolated from the nonsaponifiable lipid
fraction of sasanqua seed oil. Sasanquol has been found to
inhibit TPA-induced ear inflammation in mice [23].
The levels of catechins and caffeine in most species of
Camellia are lower compared to that of C. sinensis, however, C.
sasanqua showed the best apoptotic inducing activity toward
PC3 cells among different species of Camellia (Fig. 2). It is
suggested that some other molecules besides catechins in C.
sasanqua are responsible for its cytotoxic effect. We have
therefore isolated and identified eugenyl b-primeveroside as a
major component of C. sasanqua. Eugenol, a volatile phenyl-
propene that is widely distributed across the plant kingdom,
exhibits various physiological activities such as antimicrobial
[24] and acaricidal [25] activities. In the crop tomato, eugenol is
often stored as glycosides, representing an aroma precursor,
and is an important factor determining the quality of the to-
mato fruits [26]. Eugenyl b-primeveroside has been isolated
from amethanolic extract of rose flowers usingmultilayer coil
countercurrent chromatography [17]. Moreover, eugenyl b-
primeveroside has also been isolated from the fresh leaves of
C. sasanqua [27]. However, there is no report on the medical
function of eugenyl b-primeveroside.
Our studies demonstrated that eugenyl b-primeveroside
strongly inhibited PC3 cell proliferation and blocked cell cycle
Fig. 4 e Eugenyl b-primeveroside induced cell cycle arrest and apoptosis in PC3 cells. (A) PC3 and PZ-HPV-7 cells were
treated with various concentrations of eugenyl b-primeveroside at 37C for 48 hours. The effect on cell growth was
examined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay, and the percentage of cell
proliferation was calculated by defining the absorption of cells without eugenyl b-primeveroside as 100%. This
experiment was repeated three times. Bars represent the standard deviation. Asterisks indicate that the value is
significantly different from that of the control (*p < 0.05; **p < 0.01; ***p < 0.001). (B) PC3 cells were treated with 80mM of
eugenyl bb-primeveroside for the indicated duration and analyzed for PI-stained DNA content by flow cytometry. The
indicated percentages are the mean of three independent experiments, each in duplicate. Bars represent the standard
deviation. (C) PC3 cells were treated with vehicle (dimethyl sulfoxide), eugenyl b-primeveroside (80mM) for the indicated
time. Cells were then harvested and lysed for the detection of cleaved PARP, Caspase-9, Caspase-3 and b-actin protein
expression. (D) PC3 cells were treated with vehicle (dimethyl sulfoxide), eugenyl b-primeveroside (80mM) for the indicated
time. Cells were then harvested and lysed for the detection of p21, p53 and b-actin protein expression. Western blot data
presented are representative of those obtained in at least three separate experiments. Immunoblots were quantified, and
relative expression to control is indicated.
j o u rn a l o f f o o d a nd d r u g an a l y s i s 2 4 ( 2 0 1 6 ) 1 0 5e1 1 1110progression at the G1 phase transition. To better understand
the molecular mechanisms underlying eugenyl b-primevero-
side-induced cell growth inhibition and cell cycle arrest, we
determined the effect of eugenyl b-primeveroside on the
expression of key regulatory proteins. It has been well estab-
lished that p21 and p53 play important roles in the regulation
of cell cycle progression [28]. Our results demonstrated that a
significant upregulation in p21 and p53 occurred during the
G1-phase arrest in PC3 cells treated with eugenyl b-prime-
veroside. To the best of our knowledge, this is the first report
that eugenyl b-primeveroside exhibits antiproliferative activ-
ity against cancer cells.In conclusion, the use of naturally occurring compounds
in the development of antitumor agents has become a
critical topic in the scientific and industrial communities.
Many studies have reported the biological activities of C.
sinensis, but few have discussed the biological potential of
other Camellia species. In this study, C. sasanqua was
discovered to exhibit antiproliferative activity against
human prostate cancer cells and its major component
eugenyl b-primeveroside induced G1 arrest and apoptosis in
PC3 cells. Taken together, it is suggested that C. sasanqua
could be developed as an agent for the management of
human prostate cancers.
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